A Novel Small Molecular Prostaglandin Receptor EP4 Antagonist, L001, Suppresses Pancreatic Cancer Metastasis
Jiacheng He(Temple College), Weiqiang Lü(East China Normal University), Xuekui Du(Ningbo No. 2 Hospital), Junjie Yang(East China Normal University), Xian-Hua Lin(East China Normal University), Xiaolei Chai(East China Normal University), Weiwei Yu(Sir Run Run Shaw Hospital), Wei Wang(East China Normal University), Ying Zhang(East China Normal University), Yao Zhang(The Affiliated Yongchuan Hospital of Chongqing Medical University), Mingyao Liu(Texas A&M Health Science Center), Fanhui Meng(Shanghai Jiao Tong University), Hankun Zhang(East China Normal University), Yumiao Zhao(East China Normal University), Guichao Li(Fudan University Shanghai Cancer Center)
Cited by 17
Related Papers
Dual base editor catalyzes both cytosine and adenine base conversions in human cells
|Nature Biotechnology|2020|294
TOX promotes the exhaustion of antitumor CD8+ T cells by preventing PD1 degradation in hepatocellular carcinoma
|Journal of Hepatology|2019|289
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
|Cell|2024|272
Gambogic Acid Inhibits Angiogenesis and Prostate Tumor Growth by Suppressing Vascular Endothelial Growth Factor Receptor 2 Signaling
|Cancer Research|2008|237
Engineering a precise adenine base editor with minimal bystander editing
|Nature Chemical Biology|2022|183